Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Davita Inc    DVA

DAVITA INC (DVA)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Davita : Rep. Norman will hear from Fort Mill patients. What will they say?

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/12/2017 | 08:04pm EDT

Aug. 13--FORT MILL -- U.S. Rep. Ralph Norman, R-S.C., will speak with dialysis patients at 10 a.m. Monday at Fort Mill's DaVita Dialysis Center.

Norman, who was elected earlier this summer to the U.S. House of Representatives, is touring South Carolina's5th District on a listening tour before the Congressional recess ends in early September.

Norman will meet with patients and their families to hear about the "benefits of integrated care for kidney patients," according to DaVita. The congressman will hear stories about the care needed for patients living with end stage renal disease who require dialysis to survive.

DaVita says Congress will consider many important public policy issues impacting kidney care and patients in South Carolina. Norman campaigned for his Congress seat on a promise to repeal the Affordable Care Act, or "Obamacare."

A Senate bill that would strip away most of that law failed last month to gain enough Republican votes to pass.

Norman told The Herald he is looking forward to returning to Washington, D.C., to work with his colleagues on a new replacement bill.

"I haven't talked to a person yet who is happy with their insurance," he said. "They can't afford their premiums, and God help them if they get sick."

David Thackham: 803-329-4066, @dthackham

___

(c)2017 The Herald (Rock Hill, S.C.)

Visit The Herald (Rock Hill, S.C.) at www.heraldonline.com

Distributed by Tribune Content Agency, LLC.

© Tribune Content Agency, source Regional News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DAVITA INC
08/16 EARNINGS REVIEW AND FREE RESEARCH RE : DaVita’s Diluted EPS Rocketed 150%
08/16 DAVITA INC : Earnings Review and Free Research Report: DaVita’s Diluted EPS Rock..
08/12 DAVITA : Rep. Norman will hear from Fort Mill patients. What will they say?
08/11 DAVITA : The News Tribune (Tacoma, Wash.), Matt Driscoll column
08/04 DAVITA : to move 500 employees from Tacoma to Federal Way
08/04 DAVITA : City excited for expansion of DaVita corporate offices in Federal Way
08/01 DAVITA HEALTHCARE PARTNERS INC. (NYS : DVA) reported earnings of $0.92 per share..
08/01 DAVITA : Management's Discussion and Analysis of Financial Condition and Results..
08/01 DAVITA INC. (NYSE : DVA) Files An 8-K Results of Operations and Financial Condit..
08/01 DAVITA INC. : Results of Operations and Financial Condition, Financial Statement..
More news
News from SeekingAlpha
06:20a Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2017 Update
08/15 Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q2 2017 Update
08/09 VALUATION DASHBOARD : Healthcare - Update
08/08 Book Profits On Puma Biotechnology - Cramer's Lightning Round (8/7/17)
08/01 DaVita (DVA) Q2 2017 Results - Earnings Call Transcript
Financials ($)
Sales 2017 15 267 M
EBIT 2017 1 750 M
Net income 2017 910 M
Debt 2017 8 114 M
Yield 2017 -
P/E ratio 2017 11,30
P/E ratio 2018 14,69
EV / Sales 2017 1,24x
EV / Sales 2018 1,18x
Capitalization 10 751 M
Chart DAVITA INC
Duration : Period :
Davita Inc Technical Analysis Chart | DVA | US23918K1088 | 4-Traders
Technical analysis trends DAVITA INC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 67,1 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Kent J. Thiry Chairman & Chief Executive Officer
Michael D. Staffieri Chief Operating Officer-Kidney Care
Joseph C. Mello Chief Operating Officer-HealthCare Partners
Joel Ackerman Chief Financial Officer
Allen R. Nissenson Chief Medical Officer-Kidney Care
Sector and Competitors
1st jan.Capitalization (M$)
DAVITA INC-12.41%10 751
FRESENIUS MEDICAL CARE-1.73%28 533
HCA HEALTHCARE INC5.09%28 008
LABORATORY CORP. OF AMERICA HOLDINGS19.89%15 765
QUEST DIAGNOSTICS INC14.66%14 305
UNIVERSAL HEALTH SERVICES, INC.0.75%10 334